Law ❯ Litigation ❯ Class Action ❯ Investor Rights

Corporate Governance

Corcept Faces Securities Class Action Over Relacorilant Disclosures as Firms Rally Investors Before April 21 Deadline

Plaintiffs say Corcept overstated relacorilant’s approval prospects in the face of FDA concerns.

CoreWeave Faces Securities Class Action in New Jersey Federal Court

Fermi Hit With SDNY Securities Class Action Over Project Matador Disclosures

Law Firms Press Lead-Plaintiff Drive in Klarna IPO Class Action

Freeport-McMoRan Investors Face Jan. 12 Deadline in Securities Suit Over Indonesia Mine Disclosures

Freeport-McMoRan Investors Urged to Seek Lead Role in Grasberg Safety Class Action